Ironwood Pharmaceuticals | IRWD - Ebitda


Ironwood Pharmaceuticals reported $81.81M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
Acadia Pharmaceuticals USD 35.76M 447K Sep/2025
Agios Pharmaceuticals USD -115.49M 10.3M Sep/2025
Akebia Therapeutics USD 14.03M 17.19M Mar/2025
Almirall EUR 114.07M 60.37M Dec/2025
Alnylam Pharmaceuticals USD 145.22M 236.56M Dec/2025
Amarin USD 12.54M 28.57M Jun/2025
Ardelyx USD 6.02M 447K Dec/2025
Astellas Pharma JPY 183.68B 31.98B Dec/2025
AstraZeneca USD 5.23B 272M Sep/2025
Charles River Laboratories USD 258.06M 24.83M Dec/2025
Coherus Biosciences USD -43.33M 4.7M Sep/2025
Esperion Therapeutics USD -9.93M 24.99M Sep/2025
Halozyme Therapeutics USD 21.9M 226.34M Dec/2025
Incyte USD 414.5M 92.42M Dec/2025
Ironwood Pharmaceuticals USD 81.81M 31.71M Sep/2025
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Lexicon Pharmaceuticals USD -12.04M 15.95M Sep/2025
MacroGenics USD 21.95M 55.39M Sep/2025
Moderna USD -790M 582M Dec/2025
Myriad Genetics USD 14.3M 4M Dec/2025
Pacira USD 38.71M 10.65M Dec/2025
PTC Therapeutics USD 20.63M 53.74M Sep/2025
Puma Biotechnology USD 729K 11.36M Jun/2024
Sarepta Therapeutics USD -168.03M 294.45M Sep/2025
Takeda JPY 448.13B 173.98B Dec/2025
Ultragenyx Pharmaceutical USD -156.79M 65.44M Sep/2025
Vanda Pharmaceuticals USD -8.31M 2.37M Dec/2024